Clinical Trial Update: Spectralis HRA+OCT Imaging of the Retina With Autofluorescence in Sickle Cell Disease

View source ↗

Summary

Completed clinical trial evaluating retinal imaging with Spectralis HRA+OCT autofluorescence in patients with sickle cell disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Snippet

Sponsor: Medical University of South Carolina | Conditions: Sickle Cell Disease | Status: COMPLETED